It can seem perplexing or mysterious when an institutional review board (IRB) can review one study via expedited procedures, while a similar study may require full board review. And then some projects might be exempt from IRB review entirely.

Why do these different review pathways exist? And how do IRBs decide which path to take?

Watch webinar for an overview of the regulatory requirements governing these IRB review approaches. Advarra’s experts discuss what IRBs must consider, what might tip the scales for a study that could go either way, and what “expedited review” actually means.

• Presenters

Jason Rush

BS, CIP

Senior Director, Regulatory, Advarra

Lauren Hartsmith

JD, CIP

Director, Regulatory Affairs, Advarra